In the news / Cancer

NEWS
Researchers at the BIO5 Institute are working to determine causes and identify new prevention and treatment strategies for this highly prevalent disease.
 
NEWS
The COVID-19 pandemic has dramatically impacted patients with cancer and other patients who are immunocompromised. It was University of Arizona Cancer Center researchers led by Dr. Rachna Shroff, who found in a new study that those with cancer need three doses of vaccine for enough protection from the virus.
 
NEWS
Throughout the 20 years of BIO5, this institute has connected various campus departments to solve the challenges of a new period of technology growth, research that tells us more than ever, and support students at UArizona.
 
NEWS
For those with a weakened immune system, such as those undergoing chemotherapy for cancer treatment, the level of antibodies they receive from the Pfizer 2-shot COVID vaccine series may not give them the amount of anti-bodies that those without cancer receive from the vaccines and a third shot may be necessary to reach the same antibody count.
 
NEWS
UArizona researchers are responsible for an amazing breakthrough in how we treat cancer. This breakthrough is designed for cancer patients for whom current immunotherapies are ineffective. That includes 96% of all colorectal cancer patients. It also boosts existing treatments without increasing toxicity.
 
NEWS
Tucson native Dr. Rachna Shroff discusses her translational work to treat GI cancers.
 
NEWS
Researchers say using nanotechnology to deliver chemotherapy, could be a more effective way to fight aggressive tumors. Nanotechnology targets chemotherapy directly and selectively to cancerous cells.
 
NEWS
The Hispanic Health Paradox refers to Hispanics and Latinos tendency toward similar or better survival rates and health outcomes than non-Hispanic whites. The power of social support might also help explain why Hispanics and Latinos often have better disease outcomes than non-Hispanic whites, says Dr. John Ruiz, who studies the phenomenon.
 
NEWS
Dr. Melissa Herbst-Kralovetz discusses how bacteria influence female reproductive health.
 
NEWS

Nearly one quarter of the global disease burden is attributed to the elderly - a group expected to more than double by 2050. 

 
NEWS
Dr. Brittany Uhlorn discusses her career journey from scientist to science communicator.
 
NEWS
Cholangiocarcinoma is a rare, aggressive cancer affecting the bile ducts both in and outside of the liver. Experts estimate that 8000 people in the United States are diagnosed with this cancer each year, although the actual number is likely to be higher because it can be hard to diagnose and may be misclassified as other types of cancer.
 
NEWS
The FDA has approved ivosidenib Tablets (Tibsovo) for the treatment of patients with IDH1-mutant cholangiocarcinoma, as detected by an FDA-approved test, according to a press release issued by Servier Pharmaceuticals. This medication, according to Dr. Rachna Shroff of the UArizona Cancer Center, would provide a new treatment for patients.
 
NEWS
As a basic scientist and clinician, Dr. Juanita Merchant brings unique perspective to the her new role. as interim Associate Director For Basic Sciences at the UAZ Cancer Center, and hopes to cultivate bench-to-bedside translation at UArizona.
 
NEWS
University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.
 
NEWS
Dr. Jianqin Lu leads a research team which created the first nanotherapeutic platform of its kind, using a nanotechnology delivery method to make them more effective against aggressive tumors. The researchers note that their nanotechnology platform can be used to deliver a range of cancer therapeutics.
 
NEWS
The University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.
 
NEWS
Dr. Monica Yellowhair unites her cancer expertise with a love for education and her community to strive for health equity and a cancer-free Arizona. She applied for funding to study the genotoxic effects of uranium, a project that was one of the first selected for the Partnership for Native American Cancer Prevention.